These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20530695)

  • 1. Controversies in cancer stem cells: targeting embryonic signaling pathways.
    Takebe N; Ivy SP
    Clin Cancer Res; 2010 Jun; 16(12):3106-12. PubMed ID: 20530695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Notch to target cancer stem cells.
    Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L
    Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting embryonic signaling pathways in cancer therapy.
    Harris PJ; Speranza G; Dansky Ullmann C
    Expert Opin Ther Targets; 2012 Jan; 16(1):131-45. PubMed ID: 22239436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Products Inspired Modulators of Cancer Stem Cells-specific Signaling Pathways Notch and Hedgehog.
    Palermo R; Ghirga F; Piccioni MG; Bernardi F; Zhdanovskaya N; Infante P; Mori M
    Curr Pharm Des; 2018; 24(36):4251-4269. PubMed ID: 30636589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
    Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
    Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
    Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging agents that target signaling pathways in cancer stem cells.
    Yang Y; Li X; Wang T; Guo Q; Xi T; Zheng L
    J Hematol Oncol; 2020 May; 13(1):60. PubMed ID: 32456660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer stem cells: therapeutic targets.
    Stojnev S; Krstic M; Ristic-Petrovic A; Stefanovic V; Hattori T
    Gastric Cancer; 2014 Jan; 17(1):13-25. PubMed ID: 23563919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
    Bhal S; Kundu CN
    Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
    Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
    Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.